HeartSciences today released results from a clinical study of its MyoVista electrocardiogram system, touting its ability to detect myocardial relaxation abnormalities associated with left ventricular diastolic dysfunction. Results from the trial were published in the Journal of the American College of Cardiology, the Southlake, Texas-based company said. “This study of MyoVista wavelet ECG technology is […]
heartsciences
HeartSciences wins CE Mark, launches MyoVista ECG in the EU
HeartSciences said today that its MyoVista high sensitivity electrocardiograph testing device won CE Mark and launched in Europe. The Westlake, Texas.-based company’s device measures the heart’s energy per heartbeat using Continuous Wavelet Transform, a type of advanced signal processing that provides doctors with a detailed visual description of a cardiac cycle’s energy distribution. Traditional resting […]
